Ultrasound in the Assessment of Tumor Response in the Age of Targeted and Immuno-Oncology Therapies. Back to the Future
- Alternative title
-
Ultraschall zur Bewertung des Tumor-Ansprechens im Zeitalter der zielgerichteten Therapien und der Immunonkologie – Zurück in die Zukunft („Back to the Future“)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Ultrasound in the Assessment of Tumor Response in the Age of Targeted and Immuno-Oncology Therapies. Back to the Future ; volume:40 ; number:02 ; year:2019 ; pages:129-131
Ultraschall in der Medizin ; 40, Heft 02 (2019), 129-131
- Contributor
-
Tovoli, Francesco
Piscaglia, Fabio
Brkljacic, Boris
Cantisani, Vito
- DOI
-
10.1055/a-0834-8353
- URN
-
urn:nbn:de:101:1-2019061208560084371219
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tovoli, Francesco
- Piscaglia, Fabio
- Brkljacic, Boris
- Cantisani, Vito
Other Objects (12)
Targeted Therapies in Pediatric Oncology
The management of cancer in the elderly: targeted therapies in oncology
Immuno-oncology
Immuno-Oncology
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
Personalized Immuno-Oncology
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
Targeted oncology
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
The promise of Immuno-oncology: implications for defining the value of cancer treatment
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
Targeted Therapies in Pediatric Oncology
The management of cancer in the elderly: targeted therapies in oncology
Immuno-oncology
Immuno-Oncology
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
Personalized Immuno-Oncology
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
Targeted oncology
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
The promise of Immuno-oncology: implications for defining the value of cancer treatment
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
Targeted Therapies in Pediatric Oncology
The management of cancer in the elderly: targeted therapies in oncology
Immuno-oncology
Immuno-Oncology
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
Personalized Immuno-Oncology
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies
Targeted oncology
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
The promise of Immuno-oncology: implications for defining the value of cancer treatment